In order to capitalize on the market potential of the MiTiHeart® blood pump, Mohawk Innovative Technology, Inc. (MiTi®) made a strategic decision to spin off the blood pump technology and establish the MiTiHeart® Corporation, a wholly-owned subsidiary. MiTiHeart® Corporation was established as a Delaware ‘C’ corporation on February 5, 2003 to develop and market unique blood pumps for patients suffering from congestive heart failure. $15 Million in technology investment established the efficacy of the prototype MiTiHeart® blood pump and has significantly reduced the technical risks. With patent protection of the novel idea behind the MiTiHeart® LVAD, and collaborations developed with the Hershey Medical Center and other leading organizations, MiTiHeart® Corporation is ready to move into the next phase and prepare the MiTiHeart® LVAD for approval by the Food and Drug Administration (FDA). The original MiTi blood pump patents and the MiTiHeart® trademarks have been exclusively licensed to MiTiHeart® Corporation.
Mohawk Innovative Technology, Inc.
1037 Watervliet-Shaker Rd
Albany, NY 12205
518-862-4290